- Home
- / Labcorp
Labcorp
Stock Price
$204.8
2023-11-10
Market Capitalization
$17.4 B
2023-11-10
Revenue
$14.9 B
FY, 2022
Labcorp Summary
Company Summary
- Overview
- Labcorp (also known as Laboratory Corporation of America Holdings) is a life sciences company that provides diagnostic, drug development, and technology-enabled solutions. It operates through two segments: Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). The company offers pharmaceutical development, medical device and diagnostic development, crop protection product testing, chemical product testing, and other services.
- Type
- Public
- Status
- Active
- Founded
- 1995
- HQ
- Burlington, NC, US | view all locations
- Website
- https://www.labcorp.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Lance V. Berberian, Executive Vice President and Chief Information and Technology Officer
Glenn A. Eisenberg, Executive Vice President and Chief Financial Officer
Brian J. Caveney, EVP and President, Early Development Research Laboratories and Chief Medical and Scientific Officer
Operating MetricsView all
Countries (Customers)
100
FY, 2021
Patient Encounters per Week
3M
FY, 2021
Patient Encounters per Year
160M
FY, 2021
LocationsView all
2 locations detected
Burlington, NC HQ
United States
531 S Spring St
Burlington, NC
United States
358 S Main St
Labcorp Financials
Summary Financials
- Revenue (Q3, 2023)
- $3.1B
- Gross profit (Q3, 2023)
- $851.2M
- Net income (Q3, 2023)
- $183.6M
- Cash (Q3, 2023)
- $727.9M
- EBIT (Q3, 2023)
- $252.3M
- Enterprise value
- $21.1B